I think the EGX merger is a great thing for this company - in the long term.
In the short term, we have more dilution, which can only lead to trading sideways, or down. The private-equity premium is now a thing of the past, and the generous price paid for Evogenix will no doubt weigh on the share price.
Until we have Phase I trial results, my price target is $1. Maybe $2 within 2-3 years.
- Forums
- ASX - By Stock
- PTD
- dilution awaits
PTD
unknown
dilution awaits
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
P.HOTC
HotCopper
Don Currie, CEO
Don Currie
CEO
Previous Video
Next Video
SPONSORED BY The Market Online